OMEPRAZOLE AND SODIUM BICARBONATE
OMEPRAZOLE; SODIUM BICARBONATE
Approval overview OMEPRAZOLE AND SODIUM BICARBONATE is listed in Drugs@FDA under application 212587 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient OMEPRAZOLE; SODIUM BICARBONATE Form and strength CAPSULE;ORAL - 20MG;1.1GM Sponsor ANDA REPOSITORY Submission history Latest submission status date: 2020-04-30 00:00:00.
Structured Monograph
Clinical summary
Approval overview OMEPRAZOLE AND SODIUM BICARBONATE is listed in Drugs@FDA under application 212587 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient OMEPRAZOLE; SODIUM BICARBONATE Form and strength CAPSULE;ORAL - 20MG;1.1GM Sponsor ANDA REPOSITORY Submission history Latest submission status date: 2020-04-30 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.